A recent study has said that obesity could lead to ovarian cancer. Researchers at the National Cancer Institute found that, among women who had never taken hormones after menopause, obesity was associated with an almost 80 percent higher risk of ...
Read more...
BALTIMORE, Dec. 31 (UPI) -- Hormone deprivation therapy that prostate cancer patients often take gives them only a temporary fix, but U.S. researchers suggest why. Jun Luo of Johns Hopkins University and colleagues at the University of Washington and ...
Read more...
The hormone deprivation therapy that prostate cancer patients often take gives them only a temporary fix, with tumours usually regaining their hold within a couple of years. Now, researchers at Johns Hopkins have discovered critical differences in ...
Read more...
Prostate cancer cells rely on androgens, male hormones that include testosterone, to survive and grow. This hormone deprivation therapy causes tumours to shrink, however, it’’s never a cure. They tumours eventually regrow into a stronger form ...
Read more...
This hormone deprivation therapy causes tumours to shrink, however, it's never a cure. They tumours eventually regrow into a stronger form, becoming resistant to treatment. To understand why this therapy eventually fails, Luo and his colleagues ...
Read more...
Washington, Jan 1 (IANS) Hormone deprivation therapy in prostate cancer only provides temporary relief, with tumours usually regaining their hold within a couple of years. Now, researchers have discovered critical differences in the hormone receptors ...
Read more...
Overall, obese women had a 26 percent higher chance of developing ovarian cancer than women of normal weight. However, things were different when it came to obese women who had never used hormone therapy. The study found they had an 80 percent higher ...
Read more...